Xenter, the world's first TechMed™ company that has developed a healthcare intelligence platform for diagnostic evaluation and wireless medical devices that captures Physical Intelligence™ (PI) data over the XenFi™ wireless ecosystem, today announced the successful close on June 30th of its Series B financing, raising a total of $58.25 million.

The financing attracted participation from existing shareholders, prominent family offices, and healthcare investors who share the Xenter vision of transforming the way healthcare data is captured, connected, and utilized in hospitals and physicians' offices. The proceeds will support commercial launch, continued development of Xenter's proprietary technologies, manufacturing expansion, clinical and regulatory initiatives, and the acceleration of the company's integrated TechMed platform.

Xenter is a privately held TechMed company defining a new category at the intersection of medical devices, data infrastructure, and clinical AI, turning real-time high-fidelity data into a scalable intelligence layer for healthcare. Founded in 2020 by seasoned life sciences entrepreneur Richard J. Linder, Xenter is introducing novel technology solutions that connect clinical data across the continuum of care.